Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
- PMID: 29661216
- PMCID: PMC5902841
- DOI: 10.1186/s13054-018-2006-0
Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment on
-
The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.Crit Care. 2017 Dec 28;21(1):324. doi: 10.1186/s13054-017-1896-6. Crit Care. 2017. PMID: 29282149 Free PMC article. Review.
References
-
- Lamontagne F, Meade MO, Hebert PC, Asfar P, Lauzier F, Seely AJE, Day AG, Mehta S, Muscedere J, Bagshaw SM, et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 2016;42(4):542–550. doi: 10.1007/s00134-016-4237-3. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
